Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • أخبار باللغة العربية
  • +971 (0) 4 368 1644
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +971 (0) 4 368 1644 from 8 AM - 5:30 PM GMT

    • Contact
    • Contact

      +971 (0) 4 368 1644
      from 8 AM - 5:30 PM GMT

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Client Login
  • Send a Release
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Client Login
  • Send a Release
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Request More Information
  • Client Login
  • Send a Release

Dr Batra's® Launches XODerma in Dubai - A breakthrough 36-billion exosome-powered skin treatment designed for anti-ageing, repair and radiant glow
  • Middle East - Arabic

Dr Batra’s® Homeopathy Logo (PRNewsfoto/Dr Batra’s® Healthcare)

News provided by

Dr Batra’s® Healthcare

16 Feb, 2026, 09:03 GMT

Share this article

Share toX

Share this article

Share toX

DUBAI, UAE, Feb. 16, 2026 /PRNewswire/ -- Dr Batra's®, a pioneer in modern homeopathy and a trusted presence in Dubai for over 15 years, launches another powerful innovation in the UAE — Dr Batra's® XODerma. This advanced skin rejuvenation treatment uniquely blends homeopathy with cutting-edge exosome technology. Designed to deliver visible and long-lasting results in as few as three sessions, XODerma offers a safe, painless and non-invasive solution with zero downtime.

Continue Reading
Dr Batra’s® launches XODerma in Dubai, a breakthrough 36-billion exosome-powered skin treatment designed for anti-ageing, repair, and a radiant glow.
Dr Batra’s® launches XODerma in Dubai, a breakthrough 36-billion exosome-powered skin treatment designed for anti-ageing, repair, and a radiant glow.

XODerma works at a deep cellular level using exosomes—nano-sized biological messengers that activate the skin's natural repair and regeneration processes. Each session delivers 36 billion nano-sized exosomes, along with 12,000+ proteins, Botox-like peptides, 8 essential amino acids, and hyaluronic acid, helping boost collagen production, smooth fine lines, improve firmness, enhance hydration, even skin tone, and restore natural glow.

Commenting on the launch, Dr Akshay Batra, Trichologist, Fellowship in Homeopathic Cosmetology & Aesthetics and Managing Director, Dr Batra's® Healthcare, said,

"After successfully introducing exosome-based hair treatments in India & UAE, we are delighted to bring Dr Batra's® XODerma—a globally recognized skin rejuvenation therapy—to our patients. With rising skin concerns linked to pollution, stress, aging, and demanding lifestyles, people today want treatments that are quick, effective, and above all, safe. Dr Batra's® XODerma delivers visible improvements in texture, tone, and firmness in just three sessions. By combining cutting-edge exosome science with our promise of natural, side-effect–free homeopathic care, we aim to offer healthier, youthful, glowing skin in the most comfortable way possible."

XODerma is ideal for individuals seeking radiant, youthful skin without downtime or surgical approach. Each session begins with an AI-powered skin analysis assessing pigmentation, texture, fine lines, pore size, firmness, and hydration. This is followed by deep cleansing and precision infusion using a derma pen, which creates micro-channels to enable non-injectable delivery of exosomes and active ingredients into deeper skin layers.

Residents of Dubai can experience Dr Batra's® XODerma at Dr Batra's® Homeopathy Clinics, including Dubai Healthcare City (DHCC), JLT and Al Qusais. To book a consultation, visit Dr Batra's Clinic.

About Dr Batra's® Healthcare

With over 200 clinics across 7 countries, Dr Batra's® Healthcare has treated over 1.5 million patients globally. Specializing in Hair, Skin, Allergies, Women & Child Health and Mental Health, the brand is committed to holistic, side-effect-free healthcare.

Photo: https://mma.prnewswire.com/media/2903646/Dr_Batras_XODerma.jpg
Logo: https://mma.prnewswire.com/media/2762606/5487058/Dr_Batra_s_Healthcare_Logo.jpg

Modal title

Also from this source

Dr Batra's® Brings Specialised XOGEN Advance Treatment to UAE, powered with 36 Billion Exosomes for Hair Regrowth

Dr Batra's® Brings Specialised XOGEN Advance Treatment to UAE, powered with 36 Billion Exosomes for Hair Regrowth

Dr Batra's®, the world's largest chain of homeopathy clinics, present in the UAE for the last 14 years, has introduced XOGEN Advance – the most...

المزيد من الإصدارات من هذا المصدر

Explore

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Health Care & Hospitals

Health Care & Hospitals

Cosmetics and Personal Care

Cosmetics and Personal Care

New Products & Services

New Products & Services

المزيد من البيانات الصحفية في مواضيع ذات صلة

Contact PR Newswire

  • +971 (0) 4 368 1644
    from 8 AM - 5:30 PM GMT

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+971 (0) 4 368 1644
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.